Sodium orthovanadate protected cortical and hippocampal neurons after experimental subarachnoid hemorrhage by increasing BDNF and inhibiting BDNF receptor TrkB inactivation, effects that were abolished by pretreatment with the TrkB inhibitor K252a [20]. Here, NTRK2 is linked to subarachnoid hemorrhage.